Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W J Strachan

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Diabetes|December 5, 2009
Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyRiccardo E Marioni, Mark W J Strachan, Rebecca M Reynolds, et al.
Behavior Genetics|January 25, 2011
Genetic associations between fibrinogen and cognitive performance in three Scottish cohortsRiccardo E Marioni, Ian J Deary, Gordon D Murray, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 9, 2020
Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes studySheila M Grecian, Stela McLachlan, Jonathan A Fallowfield, et al.
Behavior Genetics|October 13, 2009
Genetic variants associated with altered plasma levels of C-reactive protein are not associated with late-life cognitive ability in four Scottish samplesRiccardo E Marioni, Ian J Deary, Gordon D Murray, et al.
Diabetes Care|March 18, 2021
Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398Anita Jeyam, Helen Colhoun, Stuart McGurnaghan, et al.
Diabetes Care|February 6, 2021
Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398Anita Jeyam, Helen Colhoun, Stuart McGurnaghan, et al.
Diabetes Care|December 11, 2020
Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular ComplicationsAnita Jeyam, Helen Colhoun, Stuart McGurnaghan, et al.
Atherosclerosis|April 7, 2018
Decreased iron stores are associated with cardiovascular disease in patients with type 2 diabetes both cross-sectionally and longitudinallyMilton Fabian Suárez-Ortegón, Stela McLachlan, Anna H Price, et al.
The Journal of Clinical Endocrinology and Metabolism|February 16, 2006
Second primary cancers in thyroid cancer patients: a multinational record linkage studyThekkepat C Sandeep, Mark W J Strachan, Rebecca M Reynolds, et al.
BMC Medicine|August 24, 2019
Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetesPaul M McKeigue, Athina Spiliopoulou, Stuart McGurnaghan, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Diabetes|December 5, 2009
Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyRiccardo E Marioni, Mark W J Strachan, Rebecca M Reynolds, et al.
Behavior Genetics|January 25, 2011
Genetic associations between fibrinogen and cognitive performance in three Scottish cohortsRiccardo E Marioni, Ian J Deary, Gordon D Murray, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 9, 2020
Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes studySheila M Grecian, Stela McLachlan, Jonathan A Fallowfield, et al.
Behavior Genetics|October 13, 2009
Genetic variants associated with altered plasma levels of C-reactive protein are not associated with late-life cognitive ability in four Scottish samplesRiccardo E Marioni, Ian J Deary, Gordon D Murray, et al.
Diabetes Care|March 18, 2021
Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398Anita Jeyam, Helen Colhoun, Stuart McGurnaghan, et al.
Diabetes Care|February 6, 2021
Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398Anita Jeyam, Helen Colhoun, Stuart McGurnaghan, et al.
Diabetes Care|December 11, 2020
Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular ComplicationsAnita Jeyam, Helen Colhoun, Stuart McGurnaghan, et al.
Atherosclerosis|April 7, 2018
Decreased iron stores are associated with cardiovascular disease in patients with type 2 diabetes both cross-sectionally and longitudinallyMilton Fabian Suárez-Ortegón, Stela McLachlan, Anna H Price, et al.
The Journal of Clinical Endocrinology and Metabolism|February 16, 2006
Second primary cancers in thyroid cancer patients: a multinational record linkage studyThekkepat C Sandeep, Mark W J Strachan, Rebecca M Reynolds, et al.
BMC Medicine|August 24, 2019
Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetesPaul M McKeigue, Athina Spiliopoulou, Stuart McGurnaghan, et al.
Pageof 11